Bioprinting Market: Current Bioprinting Prospects and Future Innovations

Publish Date: May 2019 | Category: Chemicals & Materials | Publisher: BCC Research | Status: Publish

The global bioprinting market should reach $1.4 billion by 2024 from $306.2 million in 2019 at a compound annual growth rate (CAGR) of 35.4% for the period 2019 to 2024.

Report Scope:

This new BCC Research report on the topic “Current Bioprinting Prospects and Future Innovations” offers a detailed perspective on bioprinting technology, its current market and future prospects. The report provides a comprehensive analysis of the trending applications of bioprinting in the market in the global context, including market forecasts and sales through 2024. The report is focused on the analysis of the bioprinting market by various product types, regions and applications.

The products that matter the most, i.e., instruments (bioprinters), reagents (bioinks), 3D cell culture products, and software and services, are discussed and analyzed. Each of these segments are sub-divided into different types (as detailed later). The emphasis is on the printing instruments, reagents, tissue products, skin substitutes, etc. The report also highlights the popular and emerging applications of bioprinting in the clinical and research domains. The end user markets, i.e., research and development, cosmetics, drug discovery, clinical and others, are analyzed in this report. Other end user markets include chemical, agrochemical, educational, hobbyist and veterinary applications. This study includes a survey of the bioprinting market in all geographic regions, including North America, Europe, and Emerging markets. The Emerging markets include regions like India, China, Korea, Taiwan, Africa, Australia, New Zealand, Canada, Latin America, among others.

The report elaborates on the critical issues and challenges facing the bioprinting industry as well as emerging trends in bioprinting technologies. It additionally features the new developments and new product launches in the global market.

The new BCC report provides relevant patent analysis and comprehensive profiles of market players in the industry. The industry structure chapter focuses on changing market trends, important manufacturers/suppliers, their market shares and product offerings. The chapter also covers mergers and acquisitions and any other collaborations or partnerships that happened during the evaluation period of this report that are expected to shape the industry.

Factors such as the strengths, weaknesses, threats and opportunities that are expected to play a role in the evolution of the bioprinting market are also evaluated. Any regulatory changes or new initiatives are highlighted explicitly.

Excluded from this report is medical 3D printing, which focuses on nonliving materials used in medical devices. Examples of medical devices that are not covered include treatment models, surgical tools and guides, prosthetics, dental restorations and crowns, and surgical implants.

Report Includes:

- 85 data tables and 27 additional tables
- Comprehensive analysis of the bioprinting technologies and their trending applications in the market at a global scale
- Analyses of the global market trends with data from 2017 to 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Segmentation of the global market by technologies and products, notably instruments (bioprinters), reagents (bioinks), 3D cell culture products, and software and services
- Focus on the popular and emerging applications of bioprinting in the clinical and research domains
- Regional dynamics of bioprinting technologies covering North America, Europe and Other emerging markets including India, China, Korea, Taiwan, Africa, Australia, New Zealand, Canada, Latin America etc.
- Discussion of new developments and new product launches in the global bioprinting market
- A relevant patent analysis
- Company profiles of market players in the industry, including 3Dynamic Systems Ltd., Aspect Biosystems, GeSiM, n3D Biosciences Inc., Organovo Holdings Inc., Prellis Biologics Inc. and regenHU Ltd.

Summary

Bioprinting is a form of additive manufacturing technology, that can be used to fabricate biomimicking 3D tissue constructs and organs. The reliability and accuracy offered by these 3D tissue structures and organ constructs have made them highly attractive for a number of applications. The use of stem cells in bioprinting has significant prospects in the area of personalized medicine, to develop customized tissues/organs for repair or for the fabrication of personalized 3D tissue models for drug toxicity testing.

There is a huge unmet demand for organs. Bioprinting of 3D organs has the potential to reduce the endless wait lists of organ donations and revolutionize the medical industry. Though a number of studies are going on catering to the development of fully, functional organs by bioprinting, a number of challenges remain. These pertain to the fabrication of complex tissues with multiple cell types, the issue of resolution, and the incorporation of vascularization, among other factors.

Despite these challenges, 3D bioprinting has undergone extensive progress and is used in many other applications. The 3D tissues being biofabricated can be used for tissue engineering and regenerative medicine. From the treatment of wounds (3D skin tissues), to craniomaxillofacial repair and orthopedic reconstructive surgeries (bone grafts), to the vascular grafts used to treat the growing number of heart disease patients—these are just some of the potential clinical applications of bioprinting. In addition, in situ bioprinters that have the ability to treat the wounds/injuries by directly printing cells at a wound site are also gaining immense popularity.

One of the main drivers of the bioprinting market are the applications of 3D tissue constructs and biofabricated organ-on-chips for in vitro drug testing. The pharmaceutical industry is constrained by a high rate of drug failures at the clinical stage. Bioprinted 3D models reproduce natural tissues very closely and, therefore, are ideal materials for in vitro drug testing and other preclinical testing studies. The potential of 3D tissues to alleviate the burden on animal testing is another reason for their increased popularity. Poietis recently launched the biofabricated skin tissue, Poieskin, which can be used for cosmetic testing applications. Moreover, a multitude research organizations and universities are
developing 3D tissue models for disease modeling, drug research and cancer studies, among others.

The bioprinting market is propelled by innovations in bioprinting technologies and products encompassing bioprinters, bioinks, software, and 3D tissue products. The number of U.S. patents issued in 2018 (through November 4, 2018) in the field of bioprinting increased to 38, from a total of 27 in 2017. The highest number of patents were issued in the category of 3D cell culture products followed by the bioinks segment. Strategic collaborations and partnerships among research institutes and bioprinting companies along with interested partners from the pharmaceuticals and cosmetics sectors are supporting the growth of bioprinting market in a big way. Other factors driving the growth of the bioprinting market include increased government grants, the rising interest of private venture capitalists supporting several bioprinting start-ups, and the increasing healthcare burden.

Table of Contents

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst’s Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights
Key Findings of the Report

Chapter 3 Market and Technology Background
3D Printing and Bioprinting
Bioprinting Process
Pre-Printing
Printing
Post-Printing
Components of Bioprinting
Bioprinters
Types of Bioinks
3D Cell Culture Platforms
Applications of 3D Bioprinting
Research Applications
Clinical Applications

Chapter 4 Market Breakdown by Technology Type
Market Analysis by Technology Type
Scaffold-Based Bioprinting
Scaffold-Free Bioprinting
Market Analysis by Product Type
Market Overview
Bioprinters
Bioprinters by Class
Bioinks
3D Cell Culture Products
Software and Services

Chapter 5 Market Breakdown by End User
Market Analysis by End Users
Market Revenue
End Users by Region
Research Institutes
Pharmaceutical and Biotechnology Companies
Cosmetics
Hospitals
Other End Users

Chapter 6 Market Breakdown by Application
Market Analysis by Applications
Market Revenue
Clinical Applications
Wound Repair
Bone and Vascular Grafts
Clinical Applications by Region
Research Applications
Market Revenue
Research Applications by Region
Organ Transplantation
Tissue Engineering and Regenerative Medicine (TERM)
Cancer Research
Drug Discovery and Toxicology Testing
Other Applications by Region

Chapter 7 Market Breakdown by Region
Market Analysis by Region
Market Revenue
Bioprinters
Market Revenue
Inkjet Bioprinters
Extrusion Bioprinters
Laser-Assisted Bioprinters
Other Bioprinters
Bioinks
Market Revenue
Natural Bioinks
Synthetic Bioinks
Other Bioinks
3D Cell Culture Products
Market Revenue
Scaffolds and Well Plates
Organ-on-Chips
In Vitro 3D Cell Products
3D Bioreactors
Software and Services
Market Revenue

Chapter 8 Industry Structure
Industry Trends
Types of Market Players
Low-Cost Bioprinters
Funding in Bioprinting Industry
Collaborations and Partnerships
Mergers and Acquisitions
Competition
Leading Manufacturers/Suppliers of Bioprinting
Bioprinters
Bioinks
3D Cell Culture Products
Software and Services

Chapter 9 Patent Review
3D Bioprinting Patent Landscape
Patent Analysis
U.S. Patents by Year
U.S. Patents by Type
U.S. Patents by Assignee
U.S. Patents for Bioprinters
U.S. Patents for Bioinks
U.S. Patents for 3D Cell Culture Products
U.S. Patents for Software
European Patent Analysis
European Patents by Year
European Patents by Type
European Patents by Company
European Patents by Country
European Patents by Assignee

Chapter 10 New Developments and Regulatory Aspects
New Product Launches in Bioprinting Technologies, 2016-October 2018
New Clinical Developments in Bioprinting
Regulatory Aspects in 3D Bioprinting
Employment of Stem Cells in Bioinks
Combination Products
Current Regulatory Developments
Regulatory Issues in Bioprinting Technologies

Chapter 11 Critical Issues in Bioprinting Technologies
Issues Related to Bioprinters
Inkjet Bioprinters
Extrusion-Based Bioprinters
Laser-Assisted Bioprinting (LAB)
Issues Related to Bioinks
Bioprinting Strategy
Printability
Biocompatibility
Biodegradability
Structural and Mechanical Properties
Issues Related to Bioprinting Technologies
Scaffold-Based vs. Scaffold-Free Bioprinting
Vascularization
Bioreactors

Chapter 12 Emerging Trends and Future Innovations in Bioprinting
Emerging Trends in Bioprinters
Coaxial Bioprinting
Multimaterial Fabrication
Affordable Printers
Emerging Trends in Bioinks
Bioink Blends
Decellularized Extracellular Matrix (dECM) Bioinks
Composite Bioinks
Emerging Trends in Bioprinting Processes
In Situ Bioprinting
Organ-on-Chips
Novel Bioreactor Platforms
4D Bioprinting

Chapter 13 Analysis of Market Opportunities
Strengths of Bioprinting Market
Rising Incidence of Diseases
Advances in Bioprinting Technology
Increased Government Initiatives and Funding
Limited Supply of Organ and Tissue Donors
Trend Towards Non-Animal Testing
Collaborations and Partnerships
Challenges for Bioprinting Market
Lack of Skilled Labor
Cost of Equipment
Technological Challenges
Opportunities for Bioprinting Market
Technological Advances
Drive to Reduce Drug Discovery Time and Costs
Personalized Medicine
Emerging Markets
Threats for Bioprinting Market
Government Regulations
Ethical Concerns

Chapter 14 Company Profiles
3DYNAMIC SYSTEMS LTD.
3SCAN
ADVANCED SOLUTIONS INC.
AETHER INC.
ALLEVI
ASPECT BIOSYSTEMS LTD.
BIO3D TECHNOLOGIES PTE LTD.
BIOGELX LTD.
BIOLIFE4D
CELLBRICKS GMBH
CELLINK AB
COLLPLANT HOLDINGS LTD.
CYFUSE BIOMEDICAL K.K.
DIGILAB INC.
ENVISONTEC INC.
GESIM
N3D BIOSCIENCES INC.
NEXT BIG INNOVATION LABS PVT. LTD.
NSCRYPT INC.
ORGANOVO HOLDINGS INC.
OXSYBIO
PANDORUM TECHNOLOGIES PVT. LTD.
POIETIS
PRELLIS BIOLOGICS INC.
REGEMAT 3D S.L.
REGENHU LTD.
SE3D INC.
SYNVIVO INC.

Chapter 15 Appendix: List of Acronyms

Choose License Type

Research Assistance

For Enquiries, Call :

+44-203-322-1521

Email : sales@trendsmarketresearch.com

Send Your Request